Samur, M. 2001. Docetaxel and liver dysfunction: Is it absolutely contraindicated?. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.24, no.3 , 319-320.

Samur, M., (2001). Docetaxel and liver dysfunction: Is it absolutely contraindicated?. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.24, no.3, 319-320.

Samur, M. "Docetaxel and liver dysfunction: Is it absolutely contraindicated?," AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.24, no.3, 319-320, 2001

Samur, M. "Docetaxel and liver dysfunction: Is it absolutely contraindicated?." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.24, no.3, pp.319-320, 2001

Samur, M. (2001) . "Docetaxel and liver dysfunction: Is it absolutely contraindicated?." AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , vol.24, no.3, pp.319-320.

@article{article, author={M Samur}, title={Docetaxel and liver dysfunction: Is it absolutely contraindicated?}, journal={AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS}, year=2001, pages={319-320} }